Sudden Cardiac Death: Clinical Trials

6 trials for Sudden Cardiac Death, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 completed, 2 unknown. 6 Phase 3.

By phase and status

PhaseTrialsStatus
Phase 36Completed 4, Unknown 2

Follow Sudden Cardiac Death: new trials by email Literature Review of Sudden Cardiac Death trials Research Report on Sudden Cardiac Death

Trials (filtered) newest first · largest first

All 6 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Cardiac Sympathetic Denervation for Prevention of Ventricular Tachyarrhythmias
Cardiac Sympathetic Denervation (CSD), Routine Care - Sudden Cardiac Death, Ventricular Tachycardia
Phase 3UnknownUniversity of California, Los Angeles402021-07-262024-01-19
Preventive VT Substrate Ablation in Ischemic Heart Disease
Ventricular tachycardia substrate-based radiofrequency ablation - Ventricular Tachycardia, Ventricular Arrythmia
Phase 3UnknownCentro Medico Teknon582021-06-012023-08-30
Micophenolate Mofetil Versus Azathioprine in Myocarditis
mycophenolate mofetil 2 g per day, azathioprine of 150 [75; 150] mg per day - Lymphocytic Myocarditis (Disorder), Heart Failure
Phase 3CompletedI.M. Sechenov First Moscow State Medical University502020-10-012025-07-15
Effect of Ranolazine on Arrhythmias and Microvolt T- Wave Alternans (MVTWA) Patients With LV Dysfunction
Ranolazine, Placebo - Sudden Cardiac Death, Ventricular Arrythmias
Phase 3CompletedAspirus Heart and Vascular Institute-Research and Education72009-09-012012-02-09
Hemodynamic Efficiency of an Hemodialysis Treatment With High Permeability in Post-resuscitation Shock
hemodialysis with high permeability (HDHP), CVVH - Cardiac Arrest, Sudden Cardiac Death
Phase 3CompletedAssistance Publique - Hôpitaux de Paris382008-11-022025-09-08
Ovatio DR and VR Implantable Cardioverter Defibrillators Post-approval Study
Ovatio DR and Ovatio VR - Sudden Cardiac Death
Phase 3CompletedELA Medical, Inc.852006-04-012012-03-02

Narrower conditions

Death, Sudden, Cardiac (6)  ·  Cardiomyopathies (2)  ·  Tachycardia, Ventricular (2)  ·  Cardiomyopathy, Dilated (1)  ·  Heart Arrest (1)  ·  Heart Failure (1)  ·  Myocardial Infarction (1)  ·  Myocardial Ischemia (1)  ·  Myocarditis (1)  ·  Shock (1)  ·  Ventricular Dysfunction, Left (1)  ·  Ventricular Fibrillation (1)

Broader conditions

Cardiovascular Diseases (6)  ·  Death (6)  ·  Death, Sudden (6)  ·  Heart Diseases (6)  ·  Pathologic Processes (6)  ·  Pathological Conditions, Signs and Symptoms (6)  ·  Heart Arrest (5)  ·  Arrhythmias, Cardiac (2)  ·  Cardiac Conduction System Disease (2)  ·  Tachycardia (2)  ·  Cardiomegaly (1)  ·  Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1)  ·  Genetic Diseases, Inborn (1)  ·  Infarction (1)  ·  Ischemia (1)

Interventions

Mycophenolic Acid (1)  ·  Ranolazine (1)  ·  Renal Dialysis (1)

Sponsors

Aspirus Heart and Vascular Institute-Research and Education (1)  ·  Assistance Publique - Hôpitaux de Paris (1)  ·  Centro Medico Teknon (1)  ·  ELA Medical, Inc. (1)  ·  I.M. Sechenov First Moscow State Medical University (1)  ·  University of California, Los Angeles (1)

Countries

United States (3)  ·  France (1)  ·  Russia (1)  ·  Spain (1)

Top investigators

Alain Cariou, MD, PhD (1)  ·  Antonio Berruezo, MD, PhD (1)  ·  David K. Murdock, MD (1)  ·  Mark J Schwartz, MS (1)  ·  Marmar Vaseghi, MD, PhD (1)  ·  Ruslan S Rud' (1)

Results publications

PMID 30974188, PMID 36227461